[1] 王丹丹,孙健伟,高峰,等.早产儿支气管肺发育不良的病因及治疗进展[J].现代临床医学,2020,46(1):69-72. [2] 邵肖梅,叶鸿瑁,丘小汕,等.实用新生儿学[M].4版.北京:人民卫生出版社,2011:395-398. [3] Jobe AH,Bancalari E. Bronchopulmonary dysplasia[J].Am J Respir Crit Care Med,2001,163(7):1723-1729. [4] 沙得哈西·卡马力汗,丁效国,杨丽,等.支气管肺发育不良早产儿的临床特征及危险因素分析[J].中国现代医学杂志,2019,29(23):98-102. [5] Klinger G,Sokolover N,Boyko V,et al. Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants[J].Am J Obstet Gyncol,2013,208(2):111-115. [6] 韩芳,衣京梅,石秀玉,等.小于32周早产儿支气管肺发育不良的危险因素分析[J].解放军医学院学报,2019,40(4):321-324,327. [7] Balany J,Bhandari V. Understanding the impact of infection,inflammation,and their persistence in the pathogenesis of bronchopulmonary dysplasia[J].Front Med,2015,2:90. [8] Prometnoy DV,Alexandrovich YS,Voronenko II. Risk factors,predictors and contemporary diagnostics of bronchopulmonary dysplasia[J].Pediatrician (St. Petersburg),2017,8(3):142-150. [9] Roseanne JSV,Wes O,Aleid GW,et al. Restricted ventilation associated with reduced neurodevelopmental impairment in preterm infants[J].Neonatology,2017,112(2):172-179. [10] 章礼真.支气管肺发育不良发病机制及防治策略研究进展[J].安徽医学,2017,38(3):385-388. [11] Rostas SE,Mcpherson C. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia:picking the right drug for the right baby[J].Neonatal network:NN,2016,35(4):234-239. [12] 谭开卷,曾秋月,陈凤喜.呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素[J].医学理论与实践,2020,33(4):617-618. [13] Renjithkumar KT,Milenka CG,Binoy S. Bronchopulmonary dysplasia:a review of pathogenesis and pathophysiology[J].Respir Med,2017,132:170-177. [14] Eriksson L,Haglund B,Odlind V,et al. Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia[J].Acta Paediatrica,2015,104(3):259-263. [15] 杨耀锋,丁红辉. 早产儿解脲脲原体感染与支气管肺发育不良的相关性分析[J].中国医药导报,2015,12(3):49-52. [16] 早产儿支气管肺发育不良调查协作组.早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J].中华儿科杂志,2011,49(9):655-662. [17] 彭磊,乐功芳,陈绪萍,等.早产儿支气管肺发育不良的高危因素及防治对策[J].临床肺科杂志,2015,20(1):92-95. |